|
|
Chemotherapy and Tamoxifen Cut Long-Term Risk of Contralateral Breast Cancer
|
| Link ID |
1917 |
| Title |
Chemotherapy and Tamoxifen Cut Long-Term Risk of Contralateral Breast Cancer |
| Url |
http://www.medscape.com/viewarticle/567937?src=rss |
| Description |
Adjuvant chemotherapy and tamoxifen treatment for primary breast cancer are both independently associated with reduced risks of contralateral breast cancer that persist for up to 10 and 5 years, respectively, after the first cancer diagnosis, according to a report in the Journal of the National Cancer Institute for January 2. Reuters Health Information |
| Category |
Articles > Pharmacists |
| Keywords |
|
| Date |
Dec 27, 2007 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > Pharmacists |
| 1. |
Anakinra Plus a DMARD Improves Function in Rheumatoid Arthritis
|
|
|
The addition of anakinra to treatment with a traditional disease-modifying antirheumatic drug (DMARD) safely improves functional status in patients with active rheumatoid arthritis, according to research conducted in Europe. Reuters Health Information
|
|
|